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HepG2 cell deathClusianone is a member of the polycyclic polyprenylated acylphloroglucinol family of natural products;
its cytotoxic mechanism is unknown. Clusianone is a structural isomer of nemorosone, which is a mito-
chondrial uncoupler and a well-known cytotoxic anti-cancer agent; thus, we addressed clusianone action
at the mitochondria and its potential cytotoxic effects on cancer cells. In the HepG2 hepatocarcinoma cell
line, clusianone induced mitochondrial membrane potential dissipation, ATP depletion and phosphatidyl
serine externalization; this later event is indicative of apoptosis induction. In isolated mitochondria from
rat liver, clusianone promoted protonophoric mitochondrial uncoupling. This was evidenced by the
dissipation of mitochondrial membrane potential, an increase in resting respiration, an inhibition of
Ca2+ inﬂux, stimulation of Ca2+ efﬂux in Ca2+-loaded mitochondria, a decrease in ATP and NAD(P)H levels,
generation of ROS, and swelling of valinomycin-treated organelles in hyposmotic potassium acetate
media. The cytotoxic and uncoupling actions of clusianone were appreciably less than those of nemoro-
sone, likely due to the presence of an intra-molecular hydrogen bond with the juxtaposed carbonyl group
at the C15 position. Therefore, clusianone is capable of pharmacologically increasing the leakage of pro-
tons from the mitochondria and with favorable cytotoxicity in relation to nemorosone.
 2014 Elsevier Ireland Ltd. All rights reserved.1. Introduction histamine and ileum contractions triggered by allergens, hista-Clusianone (Fig. 1A) is a naturally occurring polyisoprenylated
benzophenone bearing a bicyclo-nonane ring; it was ﬁrst isolated
from the roots of Clusia congestiﬂora [1]. Clusianone and its C7
epimer have a wide range of biological activities, including actions
against HIV [2,3] and Epstein-Barr virus [4], cytotoxicity against
HD-MY-Z, K-562 and KE-37 tumor cell lines [5], action against
leishmaniasis [6], anti-nociceptive and anti-inﬂammatory proper-
ties [7], and antimicrobial action [8,9]. These compounds also
possess potent endothelium-dependent vasodilator effects in rat
aortic rings [10] and inhibit the allergen-induced release of tissuemine, or acetylcholine [11].
Clusianone (Fig. 1A) is a regioisomer analogue of nemorosone
(Fig. 1B), a well-known cytotoxic/anti-cancer agent [12,13]. The
separated enantiomers of nemorosone and clusianone reduce the
viability of HeLa, MIA-PaCa-2, and MCF7 cancer cells [14]. Their
structural differences occur at the position of the benzoyl group
in the bicyclo ring; the benzyl group is at the C3 and C1 position
for clusianone and nemorosone, respectively. This characteristic
of clusianone favors the formation of an intramolecular hydrogen
bond involving the hydroxyl group at the C4 position.
We have recently proposed that the cytotoxic and anti-cancer
properties of nemorosone may involve its ability to uncouple
mitochondria through a protonophoric mechanism [15]. Thus,
the highly similar structures of nemorosone and clusianone
suggest a comparable cytotoxic mechanism for clusianone.
Conversely, because the hydroxyl group at C4 appears to be
required for uncoupling by nemorosone [15], we expect different
uncoupling potencies for nemorosone and clusianone. Therefore,
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Fig. 1. Clusianone: rel-(1R,5R,7R)-3-benzoyl-4-hydroxy-8,8-dimethyl-1,5,7-tris(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione structure (A) and mass spectrum
(exact mass = 501,3010) (C), and nemorosone: rel-(1R,5R,7S)-1-benzoyl-4-hydroxy-8,8-dimethyl-3,5,7-tris(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
structure (B).
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in hepatocarcinoma cells (HepG2) and in isolated rat liver mito-
chondria as a plausible mechanism to explain its cytotoxicity. A
preliminary structure–activity relationship (SAR) analysis was con-
ducted for clusianone and nemorosone. This study is relevant be-
cause these compounds have potential as anti-cancer agents.2. Materials and methods
2.1. Compounds and reagents
All reagents were obtained from Sigma–Aldrich Corp. (St. Louis,
MO, USA). All stock solutions were prepared using glass-distilled
deionized water. Clusianone was kindly supplied by Prof. Luca
Rastrelli and Prof. Anna Lisa Piccinelli (Dipartimento di Scienze
Farmaceutiche, Universita‘ di Salerno, Italy). It was identiﬁed by
1D- and 2D-NMR experiments [2] and its purity was veriﬁed (c.a
98.6%) by HPLC-DAD and HPLC-MS, as well as by micrOTOF Q II
– ESI-TOF MS (Bruker Daltonics, Billerica, MA, USA) (Fig. 1C) at
the Núcleo de Pesquisas em Produtos Naturais e Sintéticos
(NPPNS), Faculdade de Ciências Farmacêuticas de Ribeirão Preto.
Stock solutions of clusianone or nemorosone were prepared in di-
methyl sulfoxide (DMSO) and added to the cell culture or mito-
chondrial reaction media at 1:1000 (v:v) dilution. Control
experiments contained only DMSO at 1:1000 dilution.
2.2. Culture of HepG2 cells
HepG2 cells were obtained from the American Type Culture Col-
lection (No. HB 8065). The cell line was cultured in Dulbecco’sModiﬁed Eagle’s Medium (DMEM from Sigma–Aldrich, USA) sup-
plemented with 10% fetal bovine serum (Gibco, Life Technologies,
USA) plus 100 lg/ml streptomycin, 100 IU/ml penicillin G and
0.25 lg/ml amphotericin (Antibiotic Antimycotic Solution from
Sigma–Aldrich, USA, Cat. No. A5955). The cells were seeded into
12-well plates (Nunc, Roskilde, Denmark), at a density of 1  105 -
cells/well in 1 ml of culture medium at 37 C, and ﬂushed with 5%
CO2 in air in a humidiﬁed incubator (Forma Series II, Thermo Fisher
Scientiﬁc Inc., MA, USA). After the 24 h incubation period, the cells
were rinsed with buffered saline (PBS, pH 7.4), and then used for
treatment schedules.2.3. Assessment of HepG2 cell viability by Annexin-V/propidium iodide
double staining
Cells were seeded into a 12-well plate at a density of
1  105 cells/well and incubated for 24 h in the absence (control)
or presence of clusianone (2.5, 5, 10, and 25 lM) or nemorosone
(5 lM). After the incubation, cells were collected and washed
with ice–cold phosphate buffered saline (PBS, pH 7.4) and bind-
ing buffer (10 mM 4-(2-hydroxyethyl)-1-piperazine ethane sul-
fonic acid (HEPES)/NaOH, 2.5 mM CaCl2, 140 mM NaCl). The
cells were then incubated with FITC-conjugated Annexin-V
(1:100 dilution) on ice for an additional 15 min. Propidium io-
dide (PI, 1 lg/ml) was added immediately prior to analysis.
The cells were analyzed using a BDFAXSCANTO™ ﬂow cytometer
(BD Bioscience, CA, USA); 10,000 cells were counted per sample.
Data were analyzed using BD FACSDIVA software (BD Biosci-
ences, CA, USA).
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The mitochondrial membrane potential was estimated using
the JC-1 probe (Molecular Probes Inc., Eugene, OR) as previously
described [16]. The JC-1 probe is a cationic dye that exhibits mem-
brane potential-dependent accumulation in mitochondria, as indi-
cated by a ﬂuorescence emission shift from green (525 ± 10 nm) to
red (590 ± 10 nm). Mitochondrial depolarization is speciﬁcally
indicated by a decrease in the red-to-green ﬂuorescence intensity
ratio [17]. The cells (1  105 cells/well) were incubated for 6 h in
12-well microtiter cell culture plates in the absence (control) or
presence of clusianone (5, 10 and 25 lM), nemorosone (5 lM) or
valinomycin (1 lM). After incubation, cells were harvested, resus-
pended in DMEMmedium, and incubated with JC-1 (1 lM) at 37 C
for 30 min. 10,000 cells were counted per sample. Relative ﬂuores-
cence intensities were monitored by the BD FAXSCANTO™ ﬂow
cytometer (BD Bioscience, CA, USA) and analyzed by Modﬁt and
Cell-Quest software (BD Biosciences, Franklin Lakes, NJ) using the
settings of FL1 (green) at 530 nm and FL2 (red) at 585 nm [18].
Cellular ATP was assessed using the ﬁreﬂy luciferin–luciferase
assay system. Cells (1  105) were incubated as described for the
viability assay; the suspension was then centrifuged at 50g for
5 min at 4 C. The pellet was treated with ice–cold 1 M HClO4
(1 ml) and centrifuged at 2000g for 10 min at 4 C. Aliquots
(100 ll) of the supernatants were neutralized with 2 M KOH
(70 ll), suspended in 100 mM Tris-(hydroxymethyl) aminometh-
ane (Tris)–HCl at pH 7.8 (1 ml ﬁnal volume), and centrifuged again.
Bioluminescence was measured in the supernatant using the Sig-
ma–Aldrich assay kit according to the manufacturer’s instructions
(Product No. FLAA) and an Auto Lumat LB953 Luminescence pho-
tometer (Perkin–Elmer Life Sciences, Wilbad, Germany).2.5. Isolation of rat liver mitochondria
Mitochondria were isolated by standard differential centrifuga-
tion [19]. Male Wistar rats weighing approximately 200 g were
sacriﬁced by decapitation; livers were immediately removed,
sliced in of medium (50 ml) consisting of 250 mM sucrose, 1 mM
ethyleneglycol-bis (b-aminoethyl)-N,N,N0,N0-tetraacetic acid
(EGTA) and 10 mM HEPES–KOH at pH 7.2, and homogenized three
times for 15 s at 1 min intervals using a Potter–Elvehjem homoge-
nizer. Homogenates were centrifuged at 580g for 5 min and the
resulting supernatant further centrifuged at 10,300g for 10 min.
Pellets were then suspended in medium (10 ml) consisting of
250 mM sucrose, 0.3 mM EGTA and 10 mM HEPES–KOH at pH
7.2, and centrifuged at 3400g for 15 min. The ﬁnal mitochondrial
pellet was suspended in medium (1 ml) consisting of 250 mM
sucrose and 10 mM HEPES–KOH at pH 7.2, and used within 3 h.
The mitochondrial protein content was determined by the Biuret
reaction.2.6. Standard incubation procedure
Mitochondria were energized with potassium succinate (5 mM)
in a standard incubation medium consisting of 125 mM sucrose,
65 mM KCl, 2 mM inorganic phosphate (K2HPO4), 10 mM HEPES–
KOH at pH 7.4, and 2.5 lM rotenone, at 30 C. For the mitochon-
drial swelling assay in hyposmotic potassium acetate medium,
mitochondria were incubated in a medium containing 54 mM
potassium acetate, 5 mM HEPES–NaOH at pH 7.1, 0.1 mM EGTA,
0.2 mM EDTA, 0.1 mM sodium azide, 0.1% bovine serum albumin,
15 lM atractyloside, 1 lM antimycin A, and 0.3 mM propranolol
(to inhibit the inner membrane anion channel) followed by 1 lM
valinomycin [20].2.7. Mitochondrial assays
Mitochondrial respiration was monitored using a temperature-
controlled computer-interfaced Clark-type oxygen electrode
(Hansatech instruments, oxytherm electrode unit, UK). Mitochon-
drial membrane potential was estimated spectroﬂuorimetrically
using safranine O (10 lM) as a probe [21] at the 495/586 nm
(ex/em) wavelength pair; these assays were performed in the pres-
ence of 0.1 mM EGTA. The Ca2+ efﬂux/uptake was monitored spec-
troﬂuorimetrically using Calcium Green 5N (150 nM, Molecular
Probes, OR, USA) as a probe, at the 506/531 nm (ex/em) wave-
length pair [22]. The H2O2 release was monitored spectroﬂuori-
metrically using Amplex red (1 lM, Molecular Probes, OR, USA)
and horseradish peroxidase (1 UI/ml) [23] at the 563/587 nm (ex/
em) wavelength pair. Oxidation of mitochondrial NAD(P)H
(NADPH + NADH) was monitored spectroﬂuorimetrically at 366/
450 nm (ex/em) wavelength pair. Spectroﬂuorescence was moni-
tored in a Model F-4500 Hitachi ﬂuorescence spectrophotometer
(Tokyo, Japan). Mitochondrial swelling was estimated spectropho-
tometrically from the decrease in the absorbance at 540 nm, using
a Model U-2910 Hitachi spectrophotometer (Japan).
2.8. ATP assay in isolated mitochondria
Mitochondrial ATP was assessed by means of the ﬁreﬂy lucif-
erin–luciferase assay system [24], as previously described [16].
After the incubation (10 min) with clusianone or nemorosone,
the mitochondrial suspension (1 mg protein/ml) was centrifuged
at 9000g for 5 min at 4 C, and the pellet was treated with ice–
cold 1 M HClO4 (1 ml). After centrifugation at 14,000g for 5 min
at 4 C, aliquots (100 ll) were drawn and processed according to
the manufacturer’s instructions (Sigma–Aldrich, USA, product No.
FLAA).
2.9. Statistical analysis
GraphPad Prism 5.0 (GraphPad Sotfware, Inc., USA) was used.
Statistical analysis was performed using a one-way ANOVA, fol-
lowed by a Student-Newman-Keuls post-hoc test for pair wise
comparisons. Results with P < 0.05 were considered to be statisti-
cally signiﬁcant. Theoretical pKa, LogP and LogD values were ob-
tained by ACD Labs software (Advanced Chemistry Development,
Inc., Toronto, Canada).3. Results
3.1. Effects of clusianone on HepG2 cell death
HepG2 cells were co-stained with Annexin V and PI. Living (via-
ble) cells exhibit no staining (Annexin V-negative and PI-negative
cells), while early apoptotic cells display phosphatidyl serine on
the outer cell membrane, which is detected by Annexin V (Annexin
V-positive and PI-negative cells). In the later stages of apoptosis,
the cells lose membrane integrity, which allows PI to enter and
bind to cellular DNA, providing a way to identify the late apopto-
tic/necrotic cells (Annexin V-positive and PI-positive cells). In con-
trast, necrotic cells lack membrane integrity, leading only to PI
staining (Annexin V-negative and PI-positive cells) [25,26]. The
incubation of HepG2 cells with clusianone (2.5–25 lM) for 24 h
led to a decrease in cell viability (Fig. 2A); nemorosone (5 lM)
was 80% more potent than clusianone at the same concentration.
The increase in clusianone concentration from 2.5 to 25 lM only
led to an approximate 20% loss in HepG2 cell viability. This was
characterized by increased percentages of Annexin V-positive
(Fig. 2B) and Annexin V and PI double-positive cells (Fig. 2C),
Fig. 2. Effects of clusianone on HepG2 cell viability. Annexin V-negative and
PI-negative cells (A), Annexin V-positive and PI-negative cells (B), Annexin V-
positive and PI-positive cells (C), and Annexin V-negative and PI-positive cells
(D). HepG2 cells (1  105) were incubated with control, clusianone (2.5, 5, 10 and
25 lM) or nemorosone (5 lM, Nem) for 24 h. The assay conditions are described
in Materials and methods. The bars are mean ± SEM of three different experi-
ments. Different letters indicate statistical differences at P < 0.05 when
compare all pairs of experimental groups according to the ANOVA and post
hoc Newman–Keuls tests.
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respectively. However, the percentage of typical necrotic (PI-posi-
tive) cells was markedly reduced (Fig. 2D). These results suggest
that at relatively low clusianone concentrations, necrosis predom-
inates and at relatively high clusianone concentrations, apoptosis
predominates. At all conditions, nemorosone was more potent
than clusianone.
3.2. Effects of clusianone on mitochondrial membrane potential and
ATP levels in HepG2 cells
Early cellular apoptosis is frequently preceded by the disruption
of mitochondrial membranes, which leads to a rapid collapse in the
electrochemical gradient [27,28]. To assess the effect of clusianone
on mitochondrial membrane potential in HepG2 cells, we used the
green-ﬂuorescent JC-1 probe, a mitochondrion-speciﬁc dye that
exists as a monomer at low membrane potentials and forms red-
ﬂuorescent ‘‘J-aggregates’’ at higher membrane potentials. Thus,
the ratio of red-to-green JC-1 ﬂuorescence depends only on the
membrane potential. Using an incubation time that does not pro-
mote cell death (6 h, result not shown), an increased clusianone
concentration resulted in a decreased red/green ﬂuorescence ratio
(Fig. 3A), indicating a concentration-dependent dissipation of
mitochondrial membrane potential in HepG2 cells. Valinomycin
was used to completely dissipate the mitochondrial membrane po-
tential (95%). Nemorosone (5 lM) induced an approximate 75%
loss in the mitochondrial membrane potential compared to the un-
treated control, an effect that was more potent than that elicited by
clusianone at the same concentration. The percentage of cells withFig. 3. Effects of clusianone on mitochondrial membrane potential (A) and ATP
levels (B) in HepG2 cells. HepG2 cells (1  105) were incubated with control,
clusianone (5, 10, and 25 lM) or nemorosone (5 lM, Nem) for 6 h. The assay
conditions are described in Section 2. The bars are mean ± SEM of three different
experiments. Different letters indicate statistical differences at P < 0.05 when
compare all pairs of experimental groups according to the ANOVA and post hoc
Newman–Keuls tests.
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and 75% when incubated for 6 h with 5, 10, and 25 lM clusianone,
respectively, and this followed the pattern of Annexin V/PI-positive
cells after a 24 h incubation. These results suggest a correlation be-
tween these events. Additionally, concentration-dependent ATP
depletion was observed after 6 h of incubation (Fig. 3B), a pattern
resembling that of mitochondrial membrane potential dissipation.
These results suggest that under this condition clusianone induces
HepG2 cell death by apoptosis via mitochondrial impairment,
which is similar to the mechanism of nemorosone. Therefore, we
then assessed the effects of clusianone on isolated rat liver
mitochondria.Fig. 4. Effects of clusianone on the respiration of isolated rat liver mitochondria
energized with succinate. Representative recordings (A) and phosphorylating (V3),
resting (V4), and uncoupled (VCCCP) respiration rates (B), respiratory control (RCR)
and ADP/O ratios (C). Mitochondria (RLM, 0.5 mg protein/ml) were added in the
standard medium supplemented with 0.1 mM EGTA, under the conditions
described in Materials and methods. The conditions were: (a) control, (b) 0.1, (c)
0.3, (d) 0.5, (e) 1 lM clusianone, and (f) 0.5 lM nemorosone (Nem). For V3 and VCCCP
determination, 100 lM ADP or 1 lM CCCP were added where indicated. V4 was
determined after ADP exhaustion. The bars represent mean ± SEM (n = 3). Different
letters indicate statistical differences at P < 0.05 when compare all pairs of
experimental groups according to the ANOVA and post hoc Newman–Keuls tests.3.3. Effects of clusianone on the respiration of isolated rat liver
mitochondria
Fig. 4 shows the effects of clusianone or nemorosone on succi-
nate-supported respiration in isolated rat liver mitochondria; the
phosphorylating (V3), resting (V4) and CCCP-induced uncoupling
(VCCCP) states were assessed. Typical traces in Fig. 4A show that
the treatment of mitochondrial suspension with 0.1–1 lM clusia-
none (lines b–e) resulted in a concentration-dependent increase
in V4, reaching an approximate 300% increase in the oxygen con-
sumption rate in the presence of 1 lM clusianone (Fig. 4B); this
indicates a mitochondrial uncoupling effect. However, V3 and VCCCP
respiration rates were not affected by clusianone, denoting a lack
of respiratory chain or ATP synthase inhibition (Fig. 4A and B).
The effect of clusianone on V4 led to a decrease in the respiratory
control ratio (RCR: V3/V4,) and ADP/O (Fig. 4C). Additionally, for
these mitochondrial parameters, nemorosone (0.5 lM) was more
potent than clusianone at the same concentration.3.4. Effects of clusianone on mitochondrial membrane potential and
Ca2+ uptake/release
Mitochondrial membrane potential is a very sensitive indicator
of the energy-coupling condition of mitochondria, and its dissipa-
tion denotes an uncoupling effect. Fig. 5A shows that clusianone
promoted a decrease in the mitochondrial membrane potential in
a concentration-dependent manner (0.1 – 5 lM, lines b–e), with
a maximal effect at 5 lM. The ﬂuorescence units (means ± SEM
at 200 s) after clusianone or nemorosone additions were:
21.57 ± 2.66 (line a), 48.34 ± 2.81 (line b), 64.02 ± 3.53
(line c), 77.68 ± 4.46 (line d), 101.12 ± 5.43 (line e), 123.14 ± 3.18
(line f); differences statistically signiﬁcant were found bet-
ween (line a) and the other lines, at P < 0.05. This result is consis-
tent with the V4 increase and suggests that clusianone promotes
proton translocation across the mitochondrial membrane. Accord-
ingly, clusianone also prevented Ca2+ uptake (Fig. 5B) or induced
Ca2+ release (Fig. 5C) when added to the medium prior to or
following the addition of mitochondria, respectively; these effects
were concentration-dependent (lines b–e). The ﬂuorescence units
(means ± SEM at 200 s) for panels B and C, respectively were:
45.45 ± 3.17 and 44.80 ± 6.34 (lines a), 46.14 ± 2.74 and
65.81 ± 5.12 (lines b), 53.96 ± 2.42 and 84.06 ± 5.42 (lines c),
131.19 ± 5.12 and 124.41 ± 6.13 (lines d), 158.55 ± 5.35 and
158.52 ± 4.87 (lines e), 174.44 ± 4.73 and 189.76 (lines f); differ-
ences statistically signiﬁcant were found between (lines a) and
the other lines, at P < 0.05. Considering that Ca2+ uptake and
retention by mitochondria is membrane potential-dependent,
these results support the uncoupling effect of clusianone. Nemoro-
sone only required a concentration of 0.5 lM to promote similar
uncoupling effects (lines f).3.5. Effect of clusianone on mitochondrial ATP levels
Fig. 6 shows that increasing concentrations of clusianone (0.5, 2
and 3 lM) induced a marked decrease in ATP levels (36%, 76% and
80%, respectively) of isolated rat liver mitochondria after an incu-
bation of 10 min. Oligomycin A (1 lg/ml), a classic F0F1 ATP syn-
thase inhibitor, was used as a positive control and diminished
the ATP concentration by 75%. This effect denotes mitochondrial
impairment and, similar to what was observed in HepG2 cells, is
likely a consequence of clusianone-promoted dissipation of the
mitochondrial membrane potential. Nemorosone (0.5 lM) de-
creased ATP levels by more than 70%, an effect that was nearly
twofold greater than that elicited by the same concentration of
clusianone.
Fig. 5. Effects of clusianone on membrane potential (A), Ca2+ uptake (B) and Ca2+
release (C) in mitochondria energized with succinate, expressed as arbitrary
ﬂuorescence units. Mitochondria (RLM, 0.5 mg protein/ml) were added in the
standard medium, under the conditions described in Section 2. The additions were:
(a) control, (b) 0.1, (c) 1, (d) 2.5, (e) 5 lM clusianone (Clus), or (f) 0.5 lM
nemorosone (Nem). 1 lM CCCP was added where indicated. Results are represen-
tative of three experiments with different mitochondrial preparations.
Fig. 6. Effects of clusianone on ATP levels of mitochondria energized with
succinate. Mitochondria (1 mg protein/ml) were incubated in the standard medium,
under the conditions described in Section 2, in the presence of oligomycin A (Olig,
1 lg/ml), control, 0.5, 2 and 3 lM clusianone, or 0.5 lM nemorosone (Nem) for
10 min. The bars represent mean ± SEM (n = 3). Different letters indicate statistical
differences at P < 0.05 when compare all pairs of experimental groups according to
the ANOVA and post hoc Newman–Keuls tests.
Fig. 7. Effects of clusianone on NAD(P)H redox status (A) and ROS generation (B).
For Panel (A), mitochondria (RLM, 1 mg protein/ml) were added in standard
medium supplemented with 100 lM EGTA and 5 lM rotenone, under the condi-
tions described in Section 2. The conditions were (a) control, (b) 0.5, (c) 1, (d)
2.5 lM clusianone or (e) 0.5 lM nemorosone. t-butyl hydroperoxide (t-BOOH,
250 lM), b-hydroxybutyrate (b-HB, 5 mM) and isocitrate (iso., 1 mM) were added
where indicated. For Panel (B), RLM (0.5 mg protein/ml) were added in the standard
medium supplemented with 0.1 mM EGTA, 1 lM Amplex red and 1 IU/ml horse-
radish peroxidase, under the conditions described in Section 2. The conditions
were: (a) control, (b) 0.5 lM, (c) 1 lM, (d) 2.5 lM clusianone, and (e) 0.5 lM
nemorosone. Data are expressed as arbitrary ﬂuorescence units. Results are
representative of three experiments with different mitochondrial preparations.
F.H.Z. Reis et al. / Chemico-Biological Interactions 212 (2014) 20–29 253.6. Effects of clusianone on mitochondrial NAD(P)H levels and ROS
generation
The reduced levels of NAD(P)H in the mitochondrial matrix is
controlled by the membrane potential-sensitive NADP+ transhy-
drogenase [29]. It is believed that under conditions of low
mitochondrial membrane potential, which can be promoted by
uncouplers, this enzyme is unable to sustain the reduced levels
of NAD(P)H. Fig. 7A shows that the pro-oxidant tert-butylhydro-
peroxide (t-BOOH) induced a slight depletion/oxidation of
NAD(P)H in the mitochondrial suspension (line a). This effect was
potentiated by clusianone, particularly at concentrations of 1 and2.5 lM (lines c and d, respectively), which supports its uncoupling
effect on mitochondria. The effect of nemorosone at 0.5 lM (line e)
was greater than that of clusianone at the same concentration (line
b). The ﬂuorescence units (means ± SEM at 350 s) after t-BOOH
addition were: 13.17 ± 1.02 (line a), 12.38 ± 0.56 (line b),
11.61 ± 0.48 (line c), 7.17 ± 0.83 (line d), 10.05 ± 0.78 (line e); dif-
ferences statistically signiﬁcant were found between (line a) and
Fig. 8. Effects of clusianone on isosmotic swelling in mitochondria energized with
succinate, in the absence (A) or presence (B) of ruthenium red (RR), and on
hyposmotic swelling in potassium acetate medium (C). The media were prepared as
described in Section 2. For Panel (A) and (B), mitochondria (RLM, 0.5 mg protein/ml)
were added in standard medium supplemented with 20 lM Ca2+. In Panel (A) the
conditions were: (a) control, (b) 0.5, (c) 1.5 and (d) 2.5 lM clusianone, (e) 0.5 lM
nemorosone, and (f) condition (a) plus 1 lM CsA. In Panel (B), RR was added after
100 s incubation. The conditions were: (a) control, (b) 2.5 lM clusianone, (c) 0.5 lM
nemorosone, (d) condition (b) plus 1 lM CsA, (e) condition (c) plus 1 lM CsA. For
Panel (C) mitochondria (RLM, 0.45 mg protein/ml) were added in standard medium
in the presence of (a) none, (b) 1 lM valinomycin, (c) condition (b) plus 0.5 lM
clusianone, (d) condition (b) plus 1 lM clusianone, (e) condition (b) plus 2 lM
clusianone, (f) condition (b) plus 0.5 lM nemorosone. Results are representative of
three experiments with different mitochondrial preparations.
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isocitrate following the addition of t-butyl hydroperoxide quickly
restored the ﬂuorescence of mitochondria to the level of the con-
trol; b-hydroxybutyrate and isocitrate are speciﬁc NAD+ and
NADP+ reductants [30], respectively.
A slight mitochondrial uncoupling could decrease ROS forma-
tion by maintaining the respiratory chain components in a more
oxidized state, making them less prone to transfer electrons to oxy-
gen [31]. As expected (Fig. 7B), clusianone (at concentrations of
0.5–2.5 lM) decreased the rate of mitochondrial ROS generation
(lines b–d) compared to the control condition (line a); a concentra-
tion of 0.5 lM nemorosone yielded similar results (line e). The
ﬂuorescence units (means ± SEM at 350 s) were: 100.4 ± 1.48 (line
a), 96.16 ± 2.73 (line b), 86.38 ± 3.92 (line c), 75.02 ± 4.63 (line d),
91.85 ± 2.15 (line e); differences statistically signiﬁcant were found
between (line a) and the other lines, at P < 0.05.
3.7. Effects of clusianone on Ca2+-mediated isotonic mitochondrial
swelling in the presence or absence of ruthenium red and on
valinomycin-mediated hyposmotic swelling
Fig. 8A demonstrates that in the presence of 20 lM Ca2+ and the
absence of ruthenium red in isotonic sucrose-based media,
clusianone inhibited mitochondrial swelling in a concentration-
dependent manner, reaching nearly full inhibition at a concentra-
tion of 2.5 lM (line d). Nemorosone, at a concentration of 0.5 lM
(line e), completely inhibited mitochondrial swelling, similarly to
cyclosporine A (CsA), the classical mitochondrial permeability
transition inhibitor (line f). The absorbance units (means ± SEM at
300 s) were: 0.895 ± 0.027 (line a), 0.990 ± 0.032 (line b),
1.215 ± 0.046 (line c), 1.244 ± 0.041 (line d), 1.253 ± 0.025 (line e),
1.274 ± 0.032 (line f); differences statistically signiﬁcant were
found between (line a) and the other lines, at P < 0.05. Nevertheless,
when ruthenium red was added followingmitochondrial Ca2+ load-
ing to induce cation retention (Fig. 8B), both clusianone (2.5 lM)
and nemorosone (0.5 lM) (lines b and c) induced extensive CsA-
sensitive mitochondrial swelling (lines d and e), which corresponds
to the mitochondrial permeability transition process [32]. The
absorbance units (means ± SEM at 300 s) were: 0.804 ± 0.031
(line a), 0.671 ± 0.022 (line b), 0.697 ± 0.013 (line c), 0.869 ± 0.012
(line d), 0.865 ± 0.011 (line e); differences statistically signiﬁcant
were found between (line a) and the other lines, at P < 0.05. This
event is stimulated by the depletion of NAD(P)H (Fig. 7A), which
is important source of antioxidant defense against ROS in mito-
chondria [30].
To verify whether clusianone exhibits protonophoric properties,
mitochondrial swelling assays in hyposmotic K+-acetate media
were performed [15] (Fig. 8C). The non-energized mitochondria
were incubated with valinomycin, a K+ ionophore (line b), to drive
the movement of K+ through the inner mitochondrial membrane;
under these conditions, acetate crosses the membrane in the pro-
tonated form and generates a proton (H+) gradient within the ma-
trix. Protonophores induce mitochondrial swelling by promoting
the passage of protons from the matrix to the extra-mitochondrial
medium, allowing additional acetate, K+ and H2O inﬂux [20], which
is represented by a downward deﬂection. Under these conditions,
concentration-dependent mitochondrial swelling was observed in
the presence of clusianone (1 and 2 lM, lines d and e, respectively)
or nemorosone (0.5 lM, line f). The absorbance units (means ± SEM
at 300 s) were: 0.722 ± 0.006 (line a), 0.708 ± 0.003 (line b),
0.705 ± 0.003 (line c), 0.686 ± 0.004 (line d), 0.676 ± 0.005 (line e),
0.643 ± 0.002 (line f); differences statistically signiﬁcant were
found between (line a) and the other lines, at P < 0.05. These results
validate that clusianone uncouples mitochondria via a protono-
phoric mechanism similar to the mechanism of nemorosone,
although clusianone is less potent.4. Discussion
Clusianone (Fig. 1A) is a member of a large group of biologically
active natural products, which are termed polycyclic polyprenylat-
ed acylphloroglucinols. A diverse set of properties, including anti-
bacterial and antitumoral activities, has been attributed to this
molecule [8,9,13,14]. However, unlike nemorosone, its cytotoxic
mechanism is still unknown.
We employed the propidium iodide/Annexin V assay to evalu-
ate HepG2 cell death by necrosis or apoptosis. Clusianone caused
signiﬁcant cell death that was slightly dose-dependent. Cell death
predominantly occurred due to necrosis (PI-positive cells) at lower
clusianone concentrations and generally occurred due to apoptosis
(Annexin V-positive cells) at higher concentrations. This pattern is
partially in agreement with previous reports regarding clusianone-
mediated apoptotic cell death [5,33].
Intermembrane 
space  
Low pH
Internal MembraneMatrix  
High pH
CluHCluH
Clu¯
H+
Clu¯
CluH
Clu¯
H+
CluH
Clu¯
Fig. 9. Uncoupling mechanism of clusianone in mitochondria. By diffusion, the
weak acids (CluH) can transport protons from the intermembrane side (Low pH) to
the matrix side (High pH), where it releases a proton. Driven by the membrane
potential, the anion (Clu-) migrate back to the intermembrane side and can pick up
another proton.
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that inactivate apoptosis [34]. It is possible that at low clusianone
concentrations, there is a weak effect on mitochondria-mediated
apoptosis, which promotes programmed necrosis following death
receptor (TNFR, Fas, TRAIL) ligation [34] and activates the DNA re-
pair protein poly(ADP-ribose) polymerase (PARP). PARP, in turn,
could lead to a rapid depletion of nuclear and cytoplasmic NAD+,
followed by the inhibition of glycolysis; this process accounts for
50–70% of ATP formation in tumor cells [35,36]. Consequently,
cells that depend on glycolysis for ATP production quickly become
depleted of ATP and die by necrosis. In contrast, the activation of
mitochondria-mediated apoptosis at higher clusianone concentra-
tions may actively suppress necrosis because activated caspases
cleave and inactivate proteins required for necrosis (e.g., RIP and
PARP) [37–39].
It is noteworthy that HepG2 cell death was preceded by a con-
centration-dependent mitochondrial membrane potential dissipa-
tion and decreased mitochondrial ATP levels, suggesting that the
cytotoxic function of clusianone includes early mitochondrial
impairment, which could then lead to apoptosis via the intrinsic
pathway. It has been suggested that nemorosone is most active
as an anticancer agent against estrogen receptor (ER) positive cells,
most likely due to its antiestrogenic activity [40,41]. Taking into
account that HepG2 cells express ER [42], the nemorosone/clusia-
none interaction with this receptor could also contribute to HepG2
cell death. It has been demonstrated that the removal of the
3-hydroxyl substituent from estradiol signiﬁcantly decreases
receptor binding [43]. Because nemorosone and clusianone contain
a hydroxyl group capable of mimicking the hydroxyl group in the A
ring of estradiol, which interacts with the receptor, these
compounds could conceivably bind to and compete for the estro-
gen receptor. Thus, a lower binding capacity of clusianone to this
receptor could be expected due to the presence of an intra-molec-
ular hydrogen bond involving the hydroxyl group with the juxta-
posed carbonyl group at C15.
To understand the induction of mitochondrial impairment by
clusianone, we utilized isolated rat liver mitochondria. We provide,
for the ﬁrst time, evidence that clusianone is a protonophoric mito-
chondrial uncoupler, which is supported by the following ﬁndings:
dissipation of mitochondrial membrane potential in association
with increased resting respiration, inhibition of calcium inﬂux
and promotion of efﬂux in Ca2+-loaded mitochondria, decrease in
ATP and NAD(P)H levels, ROS generation, and induced swelling in
valinomycin-treated mitochondria incubated in hyposmotic potas-
sium acetate media. These events observed in isolated mitochon-
dria are correlated with the early mitochondrial manifestations
observed in HepG2 cells and suggest that mitochondrial uncou-
pling by clusianone is a potential primary cytotoxic mechanism.
Mitochondrial uncoupling agents are typically lipophilic weak
acids, and the protonated form passes through the mitochondrial
inner membrane to the matrix, where it deprotonates. The anion
then passes back through the membrane before accepting another
proton to continue the cycle [44,45]. Similar to nemorosone, the
chemical features that enable clusianone to uncouple mitochon-
dria consist of an acidic dissociable hydroxyl group with a pKa
equal to 4.5 ± 1 (ACD theoretical value), an electron-withdrawing
moiety (two carbonyls and a benzoyl group), and three bulky
hydrophobic isoprenyl groups that contribute to an overall lipo-
philicity of 10.3 (ACD LogP theoretical value). It is essential that
the anionic form of the protonophore can pass through the mem-
brane; consequently, the negative charge of protonophores is delo-
calized over the lipophilic anion, thereby lowering its activation
energy for movement through the membrane [44,45]. The keto–
enol equilibrium, in association with the double bond conjugation
from the 4-hydroxy to 2-keto group in clusianone, could stabilize
the anionic species via delocalization of the charge over its struc-ture, maintaining its lipophilicity at a high enough level to cross
the inner mitochondrial membrane (ACD LogDpH7.4 = 7.49) and
accumulating inside to promote uncoupling. Consequently, pro-
tonated clusianone may diffuse from the mitochondrial intermem-
brane space (lower pH) into the matrix (higher pH), dissociate and
diffuse back into the intermembrane space in its ionized form.
Then, it may be protonated again, repeating the cycle. The net re-
sult is a dissipation of the proton gradient and membrane potential
(Fig. 9).
The intramolecular H-bond will appropriate a considerable pro-
portion of a donor-hydrogen’s acidity; therefore, the extent to
which it can interact with an external base is reduced [46]. In this
case, the dissociation of the acidic proton from clusianone might be
hindered by the intramolecular bond with the carbonyl group at
C15. Evidence from 1H NMR spectra for both clusianone and nem-
orosone indicates that clusianone contains a stronger intramolecu-
lar hydrogen bond. This is evident by comparing chemical shifts in
the hydroxyl groups for each compound when the same solvent
was employed (CDCL3). The hydroxyl group of clusianone absorbs
at dH 17.8 ppm [47], and the hydroxyl group of nemorosone ab-
sorbs at dH 7–8 ppm [48], which is an approximate 10 ppm
downﬁeld shift for the former with respect to the later. This may
explain the diminished protonophoric and cytotoxic potency of
clusianone with respect to nemorosone. For nemorosone, the
potential intramolecular hydrogen bond is abrogated by the
presence of an isoprenyl group at C3 instead of a benzoyl group.
The intra-molecular hydrogen bond in clusianone does not alter
its physicochemical properties, particularly lipophilicity and
acidity, compared to those of nemorosone. Nevertheless, we have
observed that this intramolecular bonding could have a substantial
effect on mitochondrial uncoupling and the cytotoxic potency and
should be evaluated via SAR or QSAR predictive models for
mitochondrial uncouplers.
The present results demonstrate that clusianone is cytotoxic
against HepG2 cells and promotes the dissipation of mitochondrial
membrane potential via a protonophoric uncoupling mechanism.
Clusianone also induces ATP depletion, which is most likely an
early event that precedes cell death. In addition, the structure of
clusianone allows for intramolecular hydrogen bonding, which
may decrease its uncoupling potency compared to nemorosone.
Thus, it is believed that a compound capable of pharmacologically
increasing the leakage of protons from the mitochondria and with
a relatively favorable cytotoxicity, such as clusianone, has a poten-
tial as an anti-cancer agent.
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